JOSE MANUEL VALDIVIELSO REVILLA-rekin lankidetzan egindako argitalpenak (24)
2023
2022
-
Independent effects of secondary hyperparathyroidism and hyperphosphataemia on chronic kidney disease progression and cardiovascular events: An analysis from the NEFRONA cohort
Nephrology Dialysis Transplantation, Vol. 37, Núm. 4, pp. 663-672
2021
-
Clinical usefulness of anthropometric indices to predict the presence of prediabetes. Data from the Ilervas cohort
Nutrients, Vol. 13, Núm. 3, pp. 1-15
-
Health Care Costs in Patients with and without Secondary Hyperparathyroidism in Spain
Advances in Therapy, Vol. 38, Núm. 10, pp. 5333-5344
-
Subclinical atheromatosis localization and burden in a low-to-moderate cardiovascular risk population: the ILERVAS study
Revista Espanola de Cardiologia, Vol. 74, Núm. 12, pp. 1043-1054
2019
-
An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients
Expert Opinion on Therapeutic Targets, Vol. 23, Núm. 7, pp. 619-630
-
Characteristics of atheromatosis in the prediabetes stage: A cross-sectional investigation of the ILERVAS project
Cardiovascular Diabetology, Vol. 18, Núm. 1
-
Lung function measurements in the prediabetes stage: data from the ILERVAS Project
Acta Diabetologica, Vol. 56, Núm. 9, pp. 1005-1012
-
Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The ILERVAS Project
Diabetes and Metabolism
2017
-
Factors predicting cardiovascular events in chronic kidney disease patients. Role of subclinical atheromatosis extent assessed by vascular ultrasound
PLoS ONE, Vol. 12, Núm. 10
-
High Levels of Hemoglobin Promote Carotid Adventitial Vasa Vasorum Neoangiogenesis in Chronic Kidney Disease
Mediators of Inflammation, Vol. 2017
-
The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease
PLoS ONE, Vol. 12, Núm. 11
2016
-
A new gender-specific formula to estimate 24-hour urine protein from protein to creatinine ratio
Nephron, Vol. 133, Núm. 4, pp. 232-238
-
Predictors of subclinical atheromatosis progression over 2 years in patients with different stages of CKD
Clinical Journal of the American Society of Nephrology, Vol. 11, Núm. 2, pp. 287-296
-
Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 36, Núm. 4, pp. 389-396
-
Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project
Nefrologia, Vol. 36, Núm. 4, pp. 389-396
2014
-
Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: Baseline data from the NEFRONA study
BMC Nephrology, Vol. 15, Núm. 1
-
Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: The NEFRONA study
Nephrology Dialysis Transplantation, Vol. 29, Núm. 7, pp. 1415-1422
2013
2011
-
Large artery calcification on dialysis patients is located in the intima and related to atherosclerosis
Clinical Journal of the American Society of Nephrology, Vol. 6, Núm. 2, pp. 303-310